Rosenblum Mark J
Insider trades filed on SEC Form 4, newest first. SEC CIK 0001329154.
- 2
- Form 4 lines on record
- 1
- Purchases (code P)
- 0
- Sales (code S)
- Sep 2, 2026, 7:48 PM ET
- Latest filing
Companies Rosenblum Mark J reports for
- Decoy Therapeutics Inc. DCOY, Chief Financial OfficerLast filed Sep 2, 2026, 5:48 PM ET
Holdings
LockedShares owned after each company's most recent Form 4, valued at the current price. Part of InsiderScanner.
| Filed | Stock | Type | Shares | Price | Value | Traded | Owned after |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026, 5:48 PM ET (open the Form 4 on EDGAR)Award/Grant | Other | Locked | Locked | Locked | Locked | Locked | |
| Nov 20, 2025, 4:42 PM ET (open the Form 4 on EDGAR)Purchase (code P) | Buy | Locked | Locked | Locked | Locked | Locked |
- Filed Sep 2, 2026, 5:48 PM ET (open the Form 4 on EDGAR)Award/GrantOther
DCOYDecoy Therapeutics Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Nov 20, 2025, 4:42 PM ET (open the Form 4 on EDGAR)Purchase (code P)Buy
SLRXSalarius Pharmaceuticals, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
Shares, price, value, trade date and holdings after the trade are locked on 2 rows here. Included with InsiderScanner ($9.99 a month) and Signal8 Pro.
Unlock with InsiderScanner